Authors
Discussion
Loading...
Member takes
Implication
Clinical review reveals evolving disease-modifying therapies in patients with multiple sclerosis, highlighting emerging insights into underlying disease mechanisms.
Key Points
- To review the global impact of multiple sclerosis and examine how evolving therapeutic interventions clarify the biological mechanisms underlying the disease.
- Assessed global epidemiological burden across populations exceeding two million affected individuals.
- Synthesized evidence from clinical disease-modifying interventions that target multiple sclerosis progression.
- Disease-modifying interventions substantially alter clinical progression, though curative therapies remain unavailable.
- Therapeutic responses provide critical insight into the immunological and neurodegenerative mechanisms driving multiple sclerosis pathology.
Cite This Study
Reich et al. (2018) studied this question.